Sources | Names Used |
---|---|
CTRPv2 | JQ-1:vorinostat (2:1 mol/mol) |
PharmacoGx | JQ-1:vorinostat (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CEP55 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | DST | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | RC3H1 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | MDM4 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | ANXA5 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-05 |
mRNA | RPRD2 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | CD109 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | NTN3 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | SNX8 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | RAB40B | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |